This product is used for in vitro qualitative detection of Treponema Pallidum (TP) antibodies in human serum and plasma and for determining the antibody titers.

• Reduced Complexity

Eliminates the strict requirement for a second, different treponemal test when TP-PA is used upfront, provided it is followed by a quantitative NTT.

• Enhanced Accuracy

TP-PA minimizes biological false positives often encountered in automated high-throughput screening.

• Reliable Confirmation

A positive TP-PA combined with a reactive NTT confirms active syphilis, while a nonreactive NTT indicates successfully treated or very late-stage infection.